Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 108
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells | Dr Mirza S Baig, Associate Professor, Indian Institute of Technology (IIT) Indore | 2020 | Drug repurposing for COVID-19 | |
| Development of Processes for Active Pharmaceutical Ingredients towards COVID-19 | CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Pharmaceutical ingredients for COVID-19 |
| Virtual Screening and in vitro validation of SARS CoV-II Main Protease inhibitors | Dr Sharad Gupta, Associate Professor, Dr Mithun Radhakrishna, Assistant Professor, Indian Institute of Technology (IIT) Gandhinagar | 2020 | Drug repurposing for COVID-19 | |
| A Novel First AId Technique for Treating COVID-19 | Prof M Manivannan, Professor, Indian Institute of Technology (IIT) Madras | 2020 | Technique for Treating COVID-19 | |
| Identification and development of potential antiviral drug molecules against SARS-CoV-2 | Prof Shailly Tomar, Indian Institute of Technology (IIT) Roorkee | 2020 | Drug repurposing for COVID-19 | |
| Standardized Extracts and Biomarkers of Andrographis peniculata(Kalmegh) | Dr Shreyans Kumar Jain, Assistant Professor, Indian Institute of Technology (IIT), Varanasi | 2020 | Immune Modulator Against CONVID-19 | |
| Identification of novel antiviral targets for COVID-19 | Prof G Subba Rao, Associate Professor, Indian Institute of Science (IISc), Bengaluru | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| IND enabling studies and development of CDRI-4655 as anti-hyper-triglyceridemic formulation | Dr Anil Nilkanth Gaikwad, Scientist, CSIR-Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Chemotherapeutic development |
| Targeting n3CLPro main protease, spike surface protein of COVID-19 In silico screening of FDA approved compounds | Prof Ashok Patel, Assistant Professor, Indian Institute of Technology (IIT) Delhi | 2020 | Insilico identification of covid protein | |
| Computer-Aided Drug Discovery against COVID-19 | Dr Parimal Kar, Assistant Professor, Indian Institute of Technology (IIT) Indore | 2020 | Drug repurposing for COVID-19 |